Abstract Human pluripotent stem cell (hPSC)-induced NK (iNK) cells are a source of off-the-shelf cell products for universal immune therapy. Conventional methods for iNK cell regeneration from hPSCs include embryoid body (EB) formation and feeder-based expansion steps. which are time-consuming and cause instability and high costs of manufacturing. Here. https://www.truvisionhealthftp.com/